Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10041084HBVENSG00000111142.14protein_codingMETAP2NoNo10988A0A140VJE3
F8VQZ7
P50579
TVIS30033822HIVENSG00000111142.14protein_codingMETAP2NoNo10988A0A140VJE3
F8VQZ7
P50579
TVIS20050655HPVENSG00000111142.14protein_codingMETAP2NoNo10988A0A140VJE3
F8VQZ7
P50579
TVIS20050272HPVENSG00000111142.14protein_codingMETAP2NoNo10988A0A140VJE3
F8VQZ7
P50579
TVIS20050296HPVENSG00000111142.14protein_codingMETAP2NoNo10988A0A140VJE3
F8VQZ7
P50579
TCGA Plot Options
Drug Information
GeneMETAP2
DrugBank IDDB01422
Drug NameNitroxoline
Target IDBE0001534
UniProt IDP50579
Regulation Typeinhibitor
PubMed IDs21088277
CitationsShim JS, Matsui Y, Bhat S, Nacev BA, Xu J, Bhang HE, Dhara S, Han KC, Chong CR, Pomper MG, So A, Liu JO: Effect of nitroxoline on angiogenesis and growth of human bladder cancer. J Natl Cancer Inst. 2010 Dec 15;102(24):1855-73. doi: 10.1093/jnci/djq457. Epub 2010 Nov 18.
GroupsExperimental
Direct ClassificationNitroquinolines and derivatives
SMILESOC1=C2N=CC=CC2=C(C=C1)[N+]([O-])=O
Pathways
PharmGKBPA164754993
ChEMBLCHEMBL1454910